Unknown

Dataset Information

0

Mechanisms of nonalcoholic fatty liver disease and implications for surgery.


ABSTRACT:

Background

Nonalcoholic fatty liver disease (NAFLD) has become the most common form of chronic liver disease in both adults and children worldwide. Understanding the pathogenic mechanisms behind NAFLD provides the basis for identifying risk factors, such as metabolic syndrome, pancreatoduodenectomy, and host genetics, that lead to the onset and progression of the disease. The progression from steatosis to more severe forms, such as steatohepatitis, fibrosis, and cirrhosis, leads to an increased number of liver and non-liver complications.

Purpose

NAFLD-associated end-stage liver disease (ESLD) and hepatocellular carcinoma (HCC) often require surgery as the only curative treatment. In particular, the presence of NAFLD together with the coexisting metabolic comorbidities that usually occur in these patients requires careful preoperative diagnosis and peri-/postoperative management. Bariatric surgery, liver resection, and liver transplantation (LT) have shown favorable results for weight loss, HCC, and ESLD in patients with NAFLD. The LT demand and the increasing spread of NAFLD in the donor pool reinforce the already existing lack of donor organs.

Conclusion

In this review, we will discuss the diverse mechanisms underlying NAFLD, its implications for surgery, and the challenges for patient management.

SUBMITTER: Kaufmann B 

PROVIDER: S-EPMC7870612 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanisms of nonalcoholic fatty liver disease and implications for surgery.

Kaufmann Benedikt B   Reca Agustina A   Wang Baocai B   Friess Helmut H   Feldstein Ariel E AE   Hartmann Daniel D  

Langenbeck's archives of surgery 20200824 1


<h4>Background</h4>Nonalcoholic fatty liver disease (NAFLD) has become the most common form of chronic liver disease in both adults and children worldwide. Understanding the pathogenic mechanisms behind NAFLD provides the basis for identifying risk factors, such as metabolic syndrome, pancreatoduodenectomy, and host genetics, that lead to the onset and progression of the disease. The progression from steatosis to more severe forms, such as steatohepatitis, fibrosis, and cirrhosis, leads to an in  ...[more]

Similar Datasets

| S-EPMC3119461 | biostudies-literature
| S-EPMC4654456 | biostudies-literature
2011-01-05 | E-GEOD-26225 | biostudies-arrayexpress
| S-EPMC8237139 | biostudies-literature
| S-EPMC6196235 | biostudies-literature
| S-EPMC5643240 | biostudies-other
| S-EPMC7460697 | biostudies-literature